HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
5-Bromo-2-phenyl-1,3-oxazole
5-broMo-2-phenyl-1,3-oxazole · 5-BROMO-2-PHENYLOXAZOLE · 5-bromo-2-phenyloxazloe · OXAZOLE,5-BROMO-2-PHENYL-
Identifikatoren & physikalische Daten
| CAS No. | 92629-11-3 |
|---|---|
| Summenformel | C9H6BrNO |
| Durchschnittliche Molmasse | 224,05 g/mol |
| Monoisotopische Masse | 222,96328 g/mol |
| SMILES | Brc1cnc(-c2ccccc2)o1 |
| InChIKey | MSXVETKZQOUBNB-UHFFFAOYSA-N |
| PubChem CID | 2773271 |
| EC No. | 853-765-5 |
| DTXSID | DTXSID30378325 |
Chemische & physikalische Eigenschaften
| XLogP | 3 |
|---|---|
| Polarare Oberfläche (TPSA) | 26 |
| H-Brücken-Donoren | 0 |
| H-Brücken-Akzeptoren | 2 |
| Frei drehbare Bindungen | 1 |
| Schwere Atome | 12 |
| Formalladung | 0 |
| Komplexität | 147 |
| Siedepunkt | 308.3±34.0 °C(Predicted) |
| Dichte | 1.524±0.06 g/cm3 (20 ºC 760 Torr) |
| Lagerbedingungen | under inert gas (nitrogen or Argon) at 2-8°C |
| pKa (Säurekonstante) | -0.56±0.10(Predicted) |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposureRespiratory tract irritation]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (100%)Skin Irrit. 2 (100%)Eye Irrit. 2A (100%)STOT SE 3 (100%) |
| Alarmwort | Warnung |
| Gefahrenhinweise | Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302 |
Anwendungen & Verwendung
Verwenden
5-Bromo-2-phenyloxazole is used in preparation of heterocyclic compounds as Δ5-desaturase inhibitors.